← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2016Last known activity
Dec 12, 2024
Acquired by Becton Dickinson on Apr 23, 2017
Timeline
1900s
- Jun 1, 1907
C.R. Bard— Founded
2010s
- Aug 19, 2013
Medafor— Acquired
- Apr 23, 2017
Becton Dickinson— Acquired By
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (1 own, 1 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (2)
- NCT05945329Lead sponsorN/ADec 12, 2024
- NCT02985060CollaboratorPhase 2Nov 1, 2016
Details
- Founded
- New York, NY, US Jun 1, 1907
- Last known activity
- Dec 12, 2024